Pulkkinen M O, Csapo A I
Prostaglandins. 1978 Jun;15(6):1055-62. doi: 10.1016/0090-6980(78)90048-5.
In 12 dysmenorrheic patients we examined the therapeutic action of the Prostaglandin-synthesis inhibitor: Ibuprofen, a non-steroidal analgesic agent. Ibuprofen highly significantly reduced the resting pressure (P less than 0.001), active pressure (P less than 0.001) and frequency (P less than 0.05) of cyclic activity of the uterus, as well as menstrual pain (P less than 0.001). Since these effects occurred after a single oral dose of 800 mg Ibuprofen, without side effects or complications, extensive field trials are recommended with this and other PG-synthesis inhibitors, to assess their therapeutic benefits.
在12名痛经患者中,我们研究了前列腺素合成抑制剂布洛芬(一种非甾体类镇痛药)的治疗作用。布洛芬能极显著降低子宫周期性活动的静息压力(P<0.001)、主动压力(P<0.001)和频率(P<0.05),以及痛经程度(P<0.001)。由于这些效果在单次口服800毫克布洛芬后即出现,且无副作用或并发症,因此建议对这种及其他前列腺素合成抑制剂进行广泛的现场试验,以评估它们的治疗益处。